ArticleAMB Express2026
Antimicrobial activity of echinacea-loaded metal-organic framework against Pseudomonas aeruginosa.
Article in AMB Express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study evaluated the antibacterial and antibiofilm activity of Echinacea-loaded amino-functionalized UIO-66 MOF nanoparticles against clinical Pseudomonas aeruginosa isolates. Echinacea-loaded amino-functionalized UIO-66 metal-organic framework nanoparticles (UIO-66-NH₂-Ea) were synthesized and characterized using scanning electron microscopy (SEM), transmission electron microscopy (TEM), entrapment efficiency (EE%), in vitro release studies of Echinacea angustifolia, and physical stability assessments. Antibacterial assays, including minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), time-kill assays, and biofilm inhibition assays, were performed. Gene expression of arr-2 and arr-4 was analyzed using quantitative real-time polymerase chain reaction (qRT-PCR) following treatment with UIO-66-NH₂-Ea. Echinacea-loaded UIO-66-NH₂ nanoparticles showed a size of 235.0 ± 7.4 nm, PDI of 0.140 ± 0.013, and entrapment efficiency of 72.53 ± 1.83%. A sustained release (~ 60% at 72 h) was observed compared to nearly complete release of free extract within 24 h. Stability showed significant changes in particle size, PDI, and entrapment efficiency over 60 days (p < 0.001). MIC (15.62-125 µg/mL) and MBC (31.25-250 µg/mL) values were up to four-fold lower than free Echinacea angustifolia (250-500 and 250-1000 µg/mL). Time-kill assays confirmed superior bactericidal activity. Biofilm formation was significantly inhibited (p < 0.001), and arr-2 and arr-4 expression was markedly downregulated compared to free extract (p < 0.001). These findings highlight the in vitro potential of Echinacea-loaded UIO-66-NH
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.